Astal Laboratories Ltd. (ASTALLTD): Astal Laboratories Share Price rises 9.99% as stock gains today

Published: 21 September 2026 at 10:48:46 AM IST

Astal Laboratories Share Price moved higher today, with the stock rising 9.99% to Rs 76.99 from the previous close of Rs 70. The company’s market capitalisation stands at Rs 306.59 Cr, placing the move in clear focus for Astal Laboratories Share Price Today searches and broader Astal Laboratories Stock News coverage. The data confirms a same-day price rise, but it does not establish a company-specific catalyst.

For readers tracking Astal Laboratories Share Price News, the day’s move is relevant because it sits alongside a low absolute market cap, a turnover of Rs 0.06 Cr and a wide intraday range between Rs 70 and Rs 78.70. In Univest research terms, the event is best read as a verified price update rather than a story with an identified trigger. Investors watching Astal Laboratories Share Price Live can next monitor whether the move is followed by stable trading around today’s levels, and how the stock’s valuation compares with healthcare peers.

Astal Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 76.99
Previous Close	Rs 70
Today's Move	Rs 6.99 (+9.99%)
Open	Rs 70.5
High	Rs 78.7
Low	Rs 70
Turnover	Rs 0.06 crore
Market Capitalisation	Rs 306.59 crore
Market Cap Category	Micro Cap

Astal Laboratories Ltd. (ASTALLTD) rose to Rs 76.99 from the previous close of Rs 70, a move of Rs 6.99 or 9.99%. The stock opened at Rs 70.5, reached a high of Rs 78.7, recorded a low of Rs 70.

Astal Laboratories Share Price today opened at Rs 70.50, matched the day’s low of Rs 70, and moved up to an intraday high of Rs 78.70 before closing at Rs 76.99. That is a gain of Rs 6.99, or 9.99%, versus the previous close of Rs 70. The day’s move makes Astal Laboratories Stock Gaining Today a factual headline, while turnover of Rs 0.06 Cr shows the traded value associated with the session. For Astal Laboratories Share Price Update tracking, the key point is simple: the stock rose today, and the supplied data confirms the move without assigning a reason.

Astal Laboratories Ltd. (ASTALLTD) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 306.59 crore
P/E Ratio	31.49x
P/B Ratio	0.91x
ROE	32.12%
ROCE	34.78%
EPS	Rs 2.22
Book Value Per Share	Rs 76.99
Dividend Yield	0%

Astal Laboratories Ltd. (ASTALLTD) fundamental metrics show P/E 31.49x, P/B 0.91x, ROE 32.12%, ROCE 34.78%. These figures provide context only and are not a buy or sell signal.

Astal Laboratories Ltd. has a market capitalisation of Rs 306.59 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.49x, P/B at 0.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 32.12% and ROCE of 34.78%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.22, book value per share of Rs 76.99, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	31.49x
Benchmark Median P/E	32.87x
Benchmark Average P/E	48.77x
Benchmark P/E Range	3.4x to 683.5x
Company P/B Ratio	0.91x
Benchmark Median P/B	3.08x
Company ROE	32.12%
Benchmark Median ROE	11.7%
Company ROCE	34.78%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 306.59 crore
Benchmark Median Market Cap	Rs 701.78 crore

Astal Laboratories Ltd. (ASTALLTD) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Astal Laboratories Ltd. (ASTALLTD) has a P/E ratio of 31.49x, which is below the benchmark median of 32.87x, a difference of -4.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Astal Laboratories Ltd. (ASTALLTD) has a ROE of 32.12%, which is above the benchmark median of 11.7%, a difference of +174.53%. Astal Laboratories Ltd. (ASTALLTD) has a ROCE of 34.78%, which is above the benchmark median of 13.46%, a difference of +158.4%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,397.93	36.41	5.09	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,48,664.42	85.01	14.08	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,82,738.23	83.79	20.36	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,012.19	25.48	4.27	19.69	21.39
Cipla Ltd.	CIPLA	1,10,793.75	32.87	3.15	11.83	16

Astal Laboratories Ltd. (ASTALLTD) has a P/E ratio of 31.49x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 32.12% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 34.78% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Astal Laboratories Ltd. (ASTALLTD) has a market capitalisation of Rs 306.59 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Astal Laboratories

• Astal Laboratories Share Price rose 9.99% today to Rs 76.99 from Rs 70.
• The day’s range was Rs 70 to Rs 78.70, with turnover of Rs 0.06 Cr.
• Market capitalisation stands at Rs 306.59 Cr, which is below the industry median of Rs 701.78 Cr.
• P/E is 31.49 and P/B is 0.91, both useful for Astal Laboratories Stock Analysis.
• ROE of 32.12 and ROCE of 34.78 are above the sector medians in the supplied benchmark.

About Astal Laboratories

Astal Laboratories Ltd. is classified in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data does not break out product lines, revenue mix or business segments, so the most reliable description is limited to its listed sector identity and financial profile. For Astal Laboratories Stock News readers, that means the company should be viewed through its healthcare positioning, its valuation ratios and its return metrics.

The key company facts supplied here are enough to show that Astal Laboratories Share Price is trading with a market cap of Rs 306.59 Cr, a P/E of 31.49, a P/B of 0.91, ROE of 32.12 and ROCE of 34.78. EPS is Rs 2.22 and book value is Rs 76.99. In Univest coverage, that creates a concise company profile for investors tracking Astal Laboratories Latest News and Astal Laboratories Company News alongside sector peers.

Track Astal Laboratories Share Price on Univest

Use Astal Laboratories Ltd. (ASTALLTD) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Astal Laboratories Share Price on Univest for live price movement, key ratios, shareholding pattern, 52-week levels and broader market insights. Univest also helps users compare Astal Laboratories Share Price Today with sector benchmarks, peer multiples and company financials in one place. That makes it easier to follow Astal Laboratories Share Price Live and Astal Laboratories Share News without relying on scattered market updates.

Frequently Asked Questions

Why is Astal Laboratories Share Price rising today?

Ans. The supplied data confirms that Astal Laboratories Share Price rose 9.99% today, but it does not establish a company-specific catalyst. The stock closed at Rs 76.99 after trading between Rs 70 and Rs 78.70.

What is Astal Laboratories Share Price today?

Ans. Astal Laboratories Share Price today is Rs 76.99. The move represents a rise of Rs 6.99, or 9.99%, from the previous close of Rs 70, according to the supplied market data.

What is the market capitalisation of Astal Laboratories?

Ans. Astal Laboratories has a market capitalisation of Rs 306.59 Cr. That places it below the industry median market cap of Rs 701.78 Cr in the supplied healthcare benchmark set. The company operates in the Healthcare sector.

How does Astal Laboratories compare with healthcare peers?

Ans. Astal Laboratories has a lower market cap and lower P/B than the listed peers, while its ROE of 32.12 and ROCE of 34.78 are higher than every peer in the supplied comparison set.

What do Astal Laboratories earnings and book value show?

Ans. Astal Laboratories reports EPS of Rs 2.22 and book value of Rs 76.99 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.

Is Astal Laboratories expensive based on valuation?

Ans. Astal Laboratories trades at a P/E of 31.49 and a P/B of 0.91. Its P/E is slightly below the industry median, while its P/B is well below the industry median of 3.08.

What sector does Astal Laboratories belong to?

Ans. Astal Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark scope is the same industry, which includes 204 companies for comparison. The stock belongs to the Healthcare sector.

Does Astal Laboratories pay a dividend?

Ans. The supplied dividend yield for Astal Laboratories is 0. That means no current dividend yield is reflected in the data used for this article, so the stock’s move is being read through price and valuation metrics.

What should investors monitor next in Astal Laboratories Share Price?

Ans. Investors monitoring Astal Laboratories Share Price can watch whether the stock sustains above the previous close of Rs 70 and how valuation metrics compare with healthcare peers. The data confirms today’s move, not its cause.